Pages that link to "Q39536837"

The following pages link to Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers (Q39536837):

Displaying 25 items.

• Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research (Q38669576) (← links)
• Depression in chronic ketamine users: Sex differences and neural bases (Q43787168) (← links)
• 7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia. (Q49551461) (← links)
• Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature. (Q49712840) (← links)
• Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention (Q50132400) (← links)
• All-optical synaptic electrophysiology probes mechanism of ketamine-induced disinhibition (Q57060009) (← links)
• Neurometabolic abnormalities in the associative striatum in antipsychotic-naïve first episode psychosis patients (Q57144224) (← links)
• Resting-state brain network features associated with short-term skill learning ability in humans and the influence of -methyl-d-aspartate receptor antagonism (Q57488896) (← links)
• Default mode network connectivity change corresponds to ketamine's delayed glutamatergic effects (Q57796889) (← links)
• Ketamine influences the locus coeruleus norepinephrine network, with a dependency on norepinephrine transporter genotype - a placebo controlled fMRI study (Q58764387) (← links)
• Astrocytic Regulation of Glutamate Transmission in Schizophrenia (Q59128381) (← links)
• Mnemonic Discrimination Deficits in First-Episode Psychosis and a Ketamine Model Suggests Dentate Gyrus Pathology Linked to N-Methyl-D-Aspartate Receptor Hypofunction (Q59880655) (← links)
• Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition (Q60061950) (← links)
• Acute ketamine dysregulates task-related gamma-band oscillations in thalamo-cortical circuits in schizophrenia (Q64448884) (← links)
• Using Neuroimaging to Decipher the Mechanism of Action of Ketamine: A Pathway to Novel Therapeutics? (Q88116766) (← links)
• 7T 1H-MRS in major depressive disorder: a Ketamine Treatment Study (Q88634276) (← links)
• Anterior Cingulate Glutamate and GABA Associations on Functional Connectivity in Schizophrenia (Q89138630) (← links)
• Glutamatergic Deficits in Schizophrenia - Biomarkers and Pharmacological Interventions within the Ketamine Model (Q89180014) (← links)
• Neurometabolic correlates of 6 and 16 weeks of treatment with risperidone in medication-naive first-episode psychosis patients (Q89747397) (← links)
• The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders - A systematic review of magnetic resonance spectroscopy studies (Q89925235) (← links)
• Association between dynamic resting-state functional connectivity and ketamine plasma levels in visual processing networks (Q92483293) (← links)
• Differences between ketamine's short-term and long-term effects on brain circuitry in depression (Q93115999) (← links)
• Hippocampal glutamate and hippocampus subfield volumes in antipsychotic-naive first episode psychosis subjects and relationships to duration of untreated psychosis (Q94599682) (← links)
• White matter integrity, duration of untreated psychosis, and antipsychotic treatment response in medication-naïve first-episode psychosis patients (Q94599929) (← links)
• The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder (Q97520398) (← links)